ORPHA:154
Familial isolated dilated cardiomyopathy
Also known as: Familial or idiopathic dilated cardiomyopathy
Publications
1,717
88.9th percentile
Trials
0
Interventional, condition-specific
Researchers
1,177
Distinct authors in sample
Gene link
TMPO
Refuted
Readiness
5/6
Stages with a signal
Clinical definition (Orphanet)
A rare familial characterized by the dilation of left ventricle and progressively impairing of systolic ventricular function, in the absence of abnormal loading conditions or coronary artery disease sufficient to cause global systolic impairment. The disease may cause heart failure or arrhythmia. The disease is isolated when no additional atypical cardiac or extracardiac manifestations are present.
How rare: 1-9 / 100 000 — about one to nine people per hundred thousand.
Cross-references
Joined from Mondo / Orphanet. MeSH labels may enter searches; UMLS / OMIM / NCIT are stored for reference.
- MONDO:0015470
- MONDO:0700335
- UMLS:C5679590
Additional Mondo synonyms (2)
familial isolated dilated cardiomyopathy · familial or idiopathic dilated cardiomyopathy
Research stages
Trial readiness signals
Where this condition sits on an open-data research pipeline — not how close a treatment is, and not medical advice. Empty stages often mean “not in these databases under this Mondo ID,” not “impossible.”
5/6 stages with a signal
No specific-condition interventional trial, but broader-category trials exist — discuss eligibility with a clinician.
- Gene identifiedPartial
Refuted — TMPO
- LiteraturePresent
1,717 matched papers (1,319 in last 10 years) Source
- Phenotype characterisedPresent
332 HPO annotations (e.g. Atrial fibrillation; Abnormal left ventricular function; Lipodystrophy) Source
- Animal modelPresent
48 genotype models (Mus musculus) Source
- Orphan designationNot found
No FDA or EMA orphan-drug designation matched this disease via UMLS or preferred name Source
- Interventional trialPartial
None under the specific name; 136 for broader category dilated cardiomyopathy
Biology
Genes and phenotypes
Gene–disease validity from GenCC, plus phenotypes and animal models joined from Monarch Initiative via Mondo ID — not a clinical diagnosis aid.
Do we know what causes it?
Uncertain — earlier gene claims are disputed or refuted.
GenCC classification: Refuted.
Phenotypes (Monarch / HPO)
332
Associated phenotypes · MONDO:0015470
- Atrial fibrillation
- Abnormal left ventricular function
- Lipodystrophy
- Congestive heart failure
- Muscular dystrophy
Showing 5 of 332 — open Monarch for the full list.
Animal models (Monarch / Alliance)
48
Model associations linked to this Mondo ID
- Tg(Myh6-rtTA)8585Jam/0 Tg(Myh6*/tetO-SCN5A*F1759A)#Marx/0 [background:] involves: C57BL/6 * CBA * FVB/NTac·MGI:5800485·Mus musculus
- Rbm20em3Wguo/Rbm20em3Wguo [background:] C57BL/6-Rbm20em3Wguo·MGI:7275231·Mus musculus
- Ldb3tm4Chen/Ldb3tm4Chen A1cfTg(Myh6-cre/Esr1*)1Jmk/A1cf+ [background:] involves: 129S1/Sv * 129X1/SvJ * Black Swiss * FVB/N·MGI:3832390·Mus musculus
- Tnnt2tm2Mmto/Tnnt2tm2Mmto [background:] involves: 129S/SvEv * C57BL/6·MGI:3804498·Mus musculus
- Destm1Cap/Destm1Cap [background:] involves: 129S7/SvEvBrd * C57BL/6·MGI:2178322·Mus musculus
- Lmnatm3Stw/Lmnatm3Stw [background:] involves: 129S1/Sv * 129S4/SvJaeSor * C57BL·MGI:3589459·Mus musculus
- Tg(Myh6-LDB3*S196L)93Mva/0 [background:] involves: C57BL/6J·MGI:5910334·Mus musculus
- Lmnatm1Stw/Lmnatm1Stw [background:] involves: 129S1/Sv·MGI:2177931·Mus musculus
- Ldb3tm4Chen/Ldb3tm4Chen Myl2tm1(cre)Krc/Myl2+ [background:] involves: 129S1/Sv * 129S4/SvJae * 129X1/SvJ * Black Swiss·MGI:3832389·Mus musculus
- H2-Ab1b-tm1Gru/H2-Ab1b-tm1Gru Tg(CD2-CD4,HLA-DQA1,HLA-DQB1)1Ell/Tg(CD2-CD4,HLA-DQA1,HLA-DQB1)1Ell [background:] NOD.Cg-H2-Ab1b-tm1Gru Tg(CD2-CD4,HLA-DQA1,HLA-DQB1)1Ell·MGI:3623997·Mus musculus
- Tnnt2tm2.1Feah/Tnnt2+ [background:] involves: 129S6/SvEvTac * FVB/N·MGI:5910772·Mus musculus
- Sgcdtm1Kcam/Sgcdtm1Kcam [background:] involves: 129S1/Sv * 129X1/SvJ·MGI:3618464·Mus musculus
Monarch fetch 2026-07-29
Therapies
Designations, candidates, and chemicals
FDA OOPD and EMA orphan designations, Open Targets clinical candidates, and CTD chemical associations via MyDisease.info. These never change the interventional-trial headline.
Orphan designation (FDA · EMA)
No designation matched this disease via UMLS or preferred name on the FDA OOPD mirror or EMA orphan register. Absence here is not proof that none exists under another wording.
Open Targets candidates
No drugs or clinical candidates returned for this Mondo ID on Open Targets.
CTD chemicals (MyDisease.info)
No CTD chemical associations returned for this Mondo ID.
Literature
Is anyone studying this?
1,717
1,717 papers have been published on this condition. That is a real research literature — still far smaller than common diseases (breast cancer: over 700,000 papers). Median papers in the last 10 years for a rare disease in this dataset (publications denominator n=3967) is 59.
1,717 papers since the earliest indexed year in this search — median last-10-year count for a rare disease in this dataset is 59 (publications denominator n=3967).
1,319 in the last 10 years · high confidence · 88.9th percentile (publications denominator)
Phrase hits: 36 · MeSH hits: 0
Who's working on it?
1,177
Distinct author names in 200 sampled papers — named people below.
Who's working on it?
No interventional trial matched this name; these authors publish on it in the sampled literature — a practical starting point for contact.
- 01Nema R14 papers · 2026
Department of Bioscience, Manipal University Jaipur, University Jaipur, Dehmi Kalan, Jaipur-Ajmer Expressway, Jaipur, Rajasthan, 303007, India.
Papers in Europe PMC - 02Vats P14 papers · 2026
Department of Bioscience, Manipal University Jaipur, University Jaipur, Dehmi Kalan, Jaipur-Ajmer Expressway, Jaipur, Rajasthan, 303007, India.
Papers in Europe PMC - 03Wang J11 papers · 2026
Department of Chemistry, School of Science, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-0033, Japan. ohkoshi@chem.s.u-tokyo.ac.jp.
Papers in Europe PMC - 04Baweja B9 papers · 2026
Department of Biosciences, Manipal University Jaipur, Dehmi Kalan, Jaipur-Ajmer Expressway, Jaipur, Rajasthan, India.
Papers in Europe PMC - 05Saini C8 papers · 2026
Department of Biosciences, Manipal University Jaipur, Dehmi Kalan, Jaipur-Ajmer Expressway, Jaipur, Rajasthan, 303007, India.
Papers in Europe PMC - 06Nirmal S7 papers · 2026
Department of Biosciences Manipal University Jaipur, Dehmi Kalan, Jaipur-Ajmer Expressway, Jaipur, Rajasthan, India.
Papers in Europe PMC - 07Zhang Z7 papers · 2026
Division of Cardiology, Department of Medicine, University of California San Diego, La Jolla, California, United States of America.
Papers in Europe PMC - 08Kumar A6 papers · 2025
Animal Genetics Division, ICAR-Indian Veterinary Research Institute, Izatnangar, Bareilly, 243122, India.
Papers in Europe PMC - 09Wang X6 papers · 2026
Department of Occupational Medicine and Environmental Toxicology, Nantong Key Laboratory of Environmental Toxicology, School of Public Health, Nantong University, Nantong, China.
Papers in Europe PMC - 10Zhang Y6 papers · 2026
Department of Oncology, The Third Xiangya Hospital of Central South University, Changsha, China.
Papers in Europe PMC
Clinical research
Is a treatment being tested?
0
interventional trials for this specific condition
No interventional trial testing a treatment matched this specific condition name on ClinicalTrials.gov (observational studies and pan-disease registries are listed separately when present). 136 trials are registered for dilated cardiomyopathy, the broader category — shown separately because they may or may not enrol this specific subtype.
Data as of 11 September 2026 · last trial check 11 September 2026
No matched interventional trials. This is true for 77.2% of diseases in the trials denominator (5501 of 7126). Here are the researchers publishing on it.
high confidence · 38.6th percentile (trials denominator)
Recruiting interventional trials
From the matched ClinicalTrials.gov set
No interventional trial testing a treatment was found for this specific condition name on ClinicalTrials.gov.
136 interventional trials matched dilated cardiomyopathy, the broader category — listed below. Those studies are not counted in the condition-specific total.
Broader category: dilated cardiomyopathy
136
Interventional trials for the parent category, exclusive of NCT IDs already counted above. Eligibility for this subtype is not guaranteed.
Worth raising with a clinician. How we count trials.
Recruiting under the broader category
- NCT06902896·RECRUITING·Safety and Efficacy of FAP iCDC in End-stage Dilated Cardiomyopathy
Conditions: Dilated Cardiomyopathy (DCM) · Heart Failure·Matched via name phrase
- NCT07062874·NOT YET RECRUITING·Combined Effect of Aerobic and Resistance Exercise in Non Ischemic Dilated Cardiomyopathy Patients
Conditions: CARDIOMYOPATHY·Matched via name phrase
- NCT07137338·RECRUITING·A Phase 1 AAV Gene Therapy Trial Evaluating Safety and Preliminary Efficacy of RP-A701 in Subjects With BAG3 Dilated Cardiomyopathy
Conditions: Dilated Cardiomyopathy (DCM)·Matched via name phrase
- NCT06224660·RECRUITING·Modulation of SERCA2a of Intra-Myocytic Calcium Trafficking in Cardiomyopathy Secondary to Duchenne Muscular Dystrophy
Conditions: DMD-Associated Dilated Cardiomyopathy·Matched via name phrase
- NCT06236022·RECRUITING·The Effects of Sirolimus in Patients With Dilated Cardiomyopathy Infected With Kaposi Sarcoma-associated Virus
Conditions: Dilated Cardiomyopathy · Kaposi's Sarcoma-Associated Herpesvirus Infection·Matched via name phrase
- NCT07567417·NOT YET RECRUITING·Endocrinal Dysfunction Among Children With Dilated Cardiomyopathy
Conditions: Assessment of Some Hormone Levels in Children With Dilated Cardiomyopathy·Matched via name phrase
- NCT07426419·RECRUITING·An AAV Gene Therapy Trial of AFTX-201 in Adults With BAG3-Associated Dilated Cardiomyopathy (DCM)
Conditions: Dilated Cardiomyopathy (DCM) · BAG3 Mutation Associated Dilated Cardiomyopathy·Matched via name phrase
- NCT05321875·RECRUITING·Early Treatment With Candesartan vs Placebo in Genetic Carriers of Dilated Cardiomyopathy (EARLY-GENE Trial)
Conditions: Cardiomyopathy, Dilated·Matched via name phrase
- NCT07347197·NOT YET RECRUITING·Endocardial Delivery for Myocardial Regeneration Using Allogeneic iPSC-derived Cardiomyocyte Spheroids for HF With Systolic Dysfunction (EMERALD Study)
Conditions: Heart Failure · Ischemic Heart Failure · Ischemic Heart Disease · Dilated Cardiomyopathy (DCM)·Matched via name phrase
- NCT06091475·RECRUITING·Therapy to Maintain Remission in Dilated Cardiomyopathy
Conditions: Heart Failure · Cardiomyopathy, Dilated · Cardiomyopathies · Heart Diseases·Matched via name phrase
- NCT04558723·RECRUITING·Cardiac Magnetic Resonance Guidance of Implantable Cardioverter Defibrillator Implantation in Non-ischemic Dilated Cardiomyopathy
Conditions: Non-ischemic Dilated Cardiomyopathy·Matched via name phrase
- NCT05769036·RECRUITING·Conventional Biventricular Versus Left Bundle Branch Pacing on Outcomes in Heart Failure Patients
Conditions: Heart Failure · Left Bundle-Branch Block · Ischemic Cardiomyopathy · Non-ischemic Dilated Cardiomyopathy·Matched via name phrase
- NCT06794710·NOT YET RECRUITING·Early Identification and Treatment of Rare Cardiomyopathy Cohorts
Conditions: Hypertrophic Cardiomyopathy (HCM) · Dilated Cardiomyopathy (DCM) · Metabolic Cardiomyopathy · Restrictive Cardiomyopathy·Matched via name phrase
- NCT06250257·RECRUITING·Bromocriptine in Dilated Cardiomyopathy Among Women of Reproductive Age
Conditions: Dilated Cardiomyopathy·Matched via name phrase
- NCT04476901·RECRUITING·Administration of Allogeneic-MSC in Patients With Non-Ischemic Dilated Cardiomyopathy
Conditions: Non-ischemic Dilated Cardiomyopathy·Matched via name phrase
Other registries (secondary)
Broader net from EU CTIS, ISRCTN, and ICTRP when available — deduped against ClinicalTrials.gov IDs already counted above. Dual-model LLM relevance gates what we keep. These rows are not added to the interventional headline.
raw 0 · after dedupe 0 · already on CT.gov 0 · kept 0 · parent 0 · uncertain 0 · dropped 0 · fetched 2026-07-29
Source notes: ictrp: Error: ICTRP public search unavailable (WHO portal is SPA-only; SOAP needs partnership). Tried: https://apps.who.int/tri
No secondary-registry studies passed dual-model relevance for this condition name (after dedupe).
Where to find support
Condition-specific patient organisations, when Orphanet lists them, are on the disease’s Orphanet page. We also link umbrella groups that support undiagnosed and ultra-rare families.
Orphanet entry for Familial isolated dilated cardiomyopathy — check Associations / patient organisations on that page.
India — NPRD
Last verified 2026-07-26This ORPHAcode is not on our curated NPRD list (direct or Mondo-parent match). That does not decide clinical eligibility; families in India should ask a notified Centre of Excellence about current coverage.
Hand-curated for this project. ORPHAcode mappings are best-effort and may be incomplete or imprecise for umbrella categories. Parent (Mondo) matches mean the policy lists a broader category — confirm eligibility with a Centre of Excellence. Financial entitlements summarised from public policy statements and may change. This is not official government guidance.
How we counted this
Europe PMC query (preferred label + any corrected label + Orphanet and Mondo exact synonyms, stoplisted; unioned with resolved MeSH labels when available). UMLS / OMIM / NCIT cross-references are stored on the overview but are not added to the query string.
("Familial isolated dilated cardiomyopathy" OR "Familial or idiopathic dilated cardiomyopathy") OR ("TMPO" OR "TMPO syndrome" OR "TMPO-related")ClinicalTrials.gov query (quoted phrases + MeSH via query.cond, plus recall-expansion terms when used):
"Familial isolated dilated cardiomyopathy" OR "Familial or idiopathic dilated cardiomyopathy"
Study-type breakdown: 0 interventional · 0 observational · 0 expanded access. Only interventional studies enter the trial headline.
Parent-category trials query:
"dilated cardiomyopathy"
Query health: ok — strategies attempted: phrase; with hits: phrase
Run this search on ClinicalTrials.gov
Confidence reasoning
- Preferred label is multi-word and distinctive
- No synonyms dropped by stoplist
- No label/synonym collisions with other diseases in this corpus
Ingested 2026-07-26T12:40:26.814Z
